Combination of AZD2171 and pemetrexed

Details for Australian Patent Application No. 2006328201 (hide)

Owner AstraZeneca AB

Inventors Wedge, Stephen Robert

Agent Davies Collison Cave

Pub. Number AU-B-2006328201

PCT Pub. Number WO2007/071970

Priority 0610708.0 31.05.06 GB; 0526132.6 22.12.05 GB

Filing date 19 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 19 August 2010

International Classifications

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/071970 Priority application(s): WO2007/071970

19 August 2010 Application Accepted

  Published as AU-B-2006328201

16 December 2010 Standard Patent Sealed

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328206-Generation of electrical power from fluid flows, particularly in oil or gas well pipes

2006328198-Substituted phenol derivatives as analgesics